[ 18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice

Nuclear Medicine and Biology

Volumn 39, Issue 1, 2012, Pages 57-64

  Paquette, Michel ^a   Ouellet, René ^a   Archambault, Mélanie ^a   Croteau, Étienne ^a   Lecomte, Roger ^a   Bénard, François ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Estrogen receptor; FES; ShRNA; Small animal PET

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; FLUORODEOXYGLUCOSE F 18; FLUOROESTRADIOL F 18; RADIOPHARMACEUTICAL AGENT; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA, HUMAN; FLUORINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG TUMOR LEVEL; ESTROGEN RECEPTOR ALPHA GENE; GENE; HORMONE BINDING; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRUS INFECTION; MOUSE; NONHUMAN; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; TUMOR GROWTH; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; SCINTISCANNING; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, ESTROGEN;

EID: 84855314868     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.06.004     Document Type: Article

References (28)

1. Clark G.M., Sledge G.W., Osborne C.K., McGuire W.L. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol 1987, 5:55-61.
2. Rose C., Thorpe S.M., Andersen K.W., Pedersen B.V., Mouridsen H.T., Blichert-Toft M. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1985, 325:16-19.
3. Berthelsen C.A., Giuliano A.E., Kern D.H., Mann B.D., Roe D.J., Morton D.L. Breast cancers: estrogen and progesterone receptor status as a predictor of in vitro chemotherapeutic response. J Surg Res 1984, 37:257-263.
4. Van de Wiele C., De Vos F., Slegers G., Van Belle S., Dierckx R.A. Radiolabeled estradiol derivatives to predict responses to hormonal treatment in breast cancer: a review. Eur J Nucl Med 2000, 27:1421-1433.
5. 18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. J Med Chem 1993, 36:1619-1629.
6. 18F-labelling of A-ring substituted 16α-fluoro-estradiols as potential radiopharmaceuticals for PET imaging. Steroids 2009, 74:42-50.
7. 18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. Nucl Med Biol 1993, 20(6):735-745.
8. Aliaga A., Rousseau J.A., Ouellet R., Cadorette J., van Lier J.E., Lecomte R., et al. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol 2004, 31:761-770.
9. Dehdashti F., Mortimer J.E., Siegel B.A., Griffeth L.K., Bonasera T.J., Fusselman M.J. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med 1995, 36:1766-1774.
10. 18F]fluoro-17β-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Can Res 1996, 2:933-939.
11. Mintun M.A., Welch M.J., Siegel B.A., Mathias C.J., Brodack J.W., McGuire A.H., et al. Breast cancer: PET imaging of estrogen receptors. Radiology 1988, 169:45-48.
12. Lanari C., Lüthy I., Lamb C.A., Fabris V., Pagano E., Helguero L.A., et al. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Can Res 2001, 61:293-302.
13. Filipowicz W. RNAi: the nuts and bolts of the RISC machine. Cell 2005, 122:17-20.
14. Dykxhoorn D.M., Lieberman J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 2005, 56:401-423.
15. Hellemans J., Mortier G., De Paepe A., Speleman F., Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007, 8:R19.
16. Brosseau J.P., Lucier J.F., Lapointe E., Durand M., Gendron D., Gervais-Bird J., et al. High-throughput quantification of splicing isoforms. RNA 2010, 16(2):442-449.
17. 18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986, 27:235-238.
18. 18F]-16α-fluoroestradiol. Nucl Med Biol 1996, 23:911-915.
19. ™ APD-based digital PET scanner. IEEE Trans Nucl Sci 2009, 56:10-16.
20. Selivanov V., Picard Y., Cadorette J., Rodrigue S., Lecomte R. Detector response models for statistical iterative image reconstruction in high resolution PET. IEEE Trans Nucl Sci 2000, 47:1168-1175.
21. Lohith T.G., Furukawa T., Mori T., Kobayashi M., Fujibayashi Y. Basic evaluation of FES-hERL PET tracer-reporter gene system for in vivo monitoring of adenoviral-mediated gene therapy. Mol Imaging Biol 2008, 10:245-252.
22. 18F-FDG PET. J Nucl Med 2009, 50(10):1598-1604.
23. Dehdashti F., Mortimer J.E., Trinkaus K., Naughton M.J., Ellis M., Katzenellenbogen J.A., et al. PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat 2009, 113(3):509-517.
24. 18F-fluoroestradiol. J Nucl Med 2008, 49:367-374.
25. 18F]fluoro-17β-oestradiol PET. Eur J Nucl Med Mol Imaging 2011, 38:37-45.
26. 18F]fluoro-17beta-estradiol. J Med Chem 2005, 48(20):6366-6378.
27. Whitten W.K. Occurrence of anoestrus in mice caged in groups. J Endocrin 1959, 18:102-107.
28. 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer. Nucl Med Biol 2011, (under press).